Brain imaging and the effects of caffeine and nicotine

References

• Magnotta VA, Heckel D, Andreasen NC, Cizadlo T, Corson PW, Ehrhardt JC, et at. Measurement of brain structures with artificial neural networks: two- and three-dimensional application. Radiology 1999; 211: 781–90.
   PubMedGoogle Scholar
• Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, et al. Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Nat! Acad Sci U S A 1998; 95: 11406–11.
   PubMed Web of Science ®Google Scholar
• Posse S, MiiIler-Gärtner HW, Dager SR. Functional magnetic resonance studies of brain activation. Sem Clin Neuro-psychiatry 1996; 1: 76–88.
   Google Scholar
• Gadian DG. NMR and its applications to living systems. 2nd edn. New York, NY: Oxford University Press; 1995: 1–283.
   Google Scholar
• Dager SR, Steen RG. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric dis-orders. Neuropsychopharmacology 1992; 6: 249–66.
   PubMedGoogle Scholar
• Fox PT, Raichle ME. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Nati Acad Sci USA 1986; 83: 1140–4.
   PubMed Web of Science ®Google Scholar
• Dager SR, Swann AC. Advances in brain metabolism research: towards a moving picture of neural activity. Biol Psychiatry 1996; 39: 231–3.
   Google Scholar
• Kaufman MJ, Levin JM. Magnetic resonance findings in substance abuse. In: Kaufman MJ, ed. Brain imaging in substance abuse: research, clinical, and forensic applications. Totowa, NJ: Humane Press; 2000: 155–98.
   Google Scholar
• Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51: 83–133.
   PubMed Web of Science ®Google Scholar
• Gilbert RM. Caffeine consumption. In: Spiller GA, ed. The methylzanthine beverages and foods: chemistry, consumption, and health effects. New York, NY: Alan R Liss; 1984: 185–213.
   Google Scholar
• Axelrod J, Reisenthal J. The fate of caffeine in man and a method for its estimation in biological material. I Pharmacol Exp Ther 1953; 107: 519–23.
   Google Scholar
• Arnaud MG. The pharmacology of caffeine. Prog Drug Res 1987; 31: 273–319.
   PubMedGoogle Scholar
• O'Brien CP. Drug addiction and drug abuse. In: Hadman JC, Limbird LE, eds. Goodman and Gilman's The pharma-cological basis of therapeutics. 9th edn. New York, NY: McGraw-Hill; 1996: 557–77.
   Google Scholar
• Rowland M, Tozer TN. Clinical pharmacokinetics. Phila-delphia, PA: Lea and Fibiger: 1980.
   Google Scholar
• Aranda JV, Collinge JM, Zinman R, Watters G. Maturation of caffeine elimination in infancy. Arch Dis Child 1979; 54: 946–49.
   PubMed Web of Science ®Google Scholar
• Hart P, Farrell GC, Cookeley WG, Powell LW. Enhanced drug metabolism in cigarette smokers. Brain Med J 1976; 2: 147–9.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders; Fourth edition Text Revision (DSM-IV-TRTm). Washington, DC: American Psychiatric Association: 1994.
   Google Scholar
• Mathews RJ, Wilson WH. Caffeine consumption, with-drawal and cerebral blood flow. Headache 1985; 25: 305–9.
   Google Scholar
• Dunwiddie TV. Endogenously released adenosine in the central nervous system. Int Rev Neurobiol 1985; 27: 63–139.
   PubMed Web of Science ®Google Scholar
• Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, meta-bolic and psychostimulant effects. Brain Res Rev 1992; 17: 139–70.
   PubMed Web of Science ®Google Scholar
• Dager SR, Layton ME, Strauss W, Richards TL, Heide A, Friedman SD, et al. Human brain metabolic response to caffeine and the effects of tolerance. Am J Psychiatry 1999; 156: 229–37.
   Google Scholar
• LaCroix AZ, Mead LA, Liang K-Y, Thomas CB, Pearson TA. Coffee consumption and the incidence of coronary heart disease. N Engl J Med 1986; 315: 977–82.
   Google Scholar
• Grobbee DE, Rimm EB, Gioyannucci E, Colditz G, Stampfer M, Willett W. Coffee, caffeine, and cardiovascular disease in men. N Engl j Med 1990; 323: 1026–32.
   PubMed Web of Science ®Google Scholar
• Sutherland GR, Peeling J, Lesiuk HJ, Brownstone RM, Rydzy M, Saunders JK, et al. The effects of caffeine on ischemic neuronal injury as determined by magnetic reson-ance imaging and histopathology. Neuroscience 1991; 42: 171–82.
   Google Scholar
• Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, et al. Association of coffee and caffeine intake with the risk of Parkinson's disease. JAMA 2000; 283: 2674–9.
   PubMed Web of Science ®Google Scholar
• Gibbs FA, Gibbs EL, Lennon WG. Cerebral blood flow in man as influenced by adrenaline, caffeine, amyl nitrite and histamine. Am Heart J 1935; 10: 916–24.
   Google Scholar
• Mathew RJ, Wilson WH. Caffeine-induced changes in cerebral circulation. Stroke 1985; 16: 814–17.
   PubMed Web of Science ®Google Scholar
• Cameron OG, Modell JG, Hariharan M. Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci 1990; 47: 1141–6.
   PubMed Web of Science ®Google Scholar
• Posse S, Dager SR, Richards TL, Yuan C, Artru AA, Ogg R, et al. In vivo measurement of regional brain metabolic response to hyperventilation using functional proton echo-planar spectroscopic imaging (PEPSI). Magn Reson Med 1997; 37: 858–65.
   Google Scholar
• Tate JC, Pomerleau CS, Pomerleau OF. Pharmacological and nonpharmacological smoking motives: a profile. J Subst Abuse 1993; 5: 391–400.
   Google Scholar
• Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: clinical phenomena and labora-tory findings. Am J Psychiatry 1998; 155: 1490–501.
   PubMed Web of Science ®Google Scholar
• Rosenberg J, Benowitz NL, Jacob P, Wilson KM. Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther 1980; 28: 517–22.
   PubMed Web of Science ®Google Scholar
• Porchet HC, Benowitz NL, Scheiner LB, Copeland JR. Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J Clin Invest 1987; 80: 1466–71.
   Google Scholar
• Benowitz NL, Jacob P III, Jones RT, Rosenberg J. Inter-individual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 1982; 221:368–71.
   PubMed Web of Science ®Google Scholar
• Dempsey D, Jacob P III, Benowitz NL. Nicotine metabolism and elimination in newborns. Clin Pharmacol Ther 2000; 67: 458–65.
   PubMed Web of Science ®Google Scholar
• Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby CR Jr. A pharmacologic strategy for the treatment of nicotine addiction. Synapse 1999; 31: 76–86.
   PubMed Web of Science ®Google Scholar
• Salokangas RKR, Vilkman H, llonen T, Taiminen T, Bergman J, Haaparanta M, et al. High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry 2000; 157: 632–34.
   PubMed Web of Science ®Google Scholar
• Jones GMM, Sahakiam BJ, Levy R, Warburton DM, Gray JA. Effects of subcutaneous nicotine on attention, infor-mation processing and short-term memory in Alzheimer's disease. Psychopharmacology 1992; 108: 485–94.
   PubMed Web of Science ®Google Scholar
• Skinhoj E, Olesen J, Paulson OB. Influence of smoking and nicotine on cerebral blood flow and metabolic rate of oxygen in man. J Appl Physiol 1973: 35,820–2.
   PubMed Web of Science ®Google Scholar
• Gotti C, Fomasari D, Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol 1997; 53: 199–237.
   PubMed Web of Science ®Google Scholar
• Decina P, Carraci G, Sandik R, Berman W, Mukherjee S, Scapicchio P. Cigarette smoking and neuroleptic-induced Parkinsonism. Biol Psychiatry 1990; 28: 502–8.
   PubMed Web of Science ®Google Scholar
• Rylander R. Relative role of aerosol and volatile constituents of cigarette smoker as agents toxic to the respiratory tract. Nat! Cancer Inst Monogr 1968; 28: 221–9.
   PubMedGoogle Scholar
• Sarabi M, Lind L. Short-term effects of smoking and nicotine chewing gum on endothelium-dependent vasodilation in young healthy habitual smokers. J Cardiovasc Pharmacol 2000; 35: 451–6.
   Google Scholar
• Neunteufl T, Priglinger U, Heher S, Zehetgruber M, Siiregi G, Lehr, et al. Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol 2000; 35: 277–83.
   PubMed Web of Science ®Google Scholar
• Friedman SD, Stidley CA, Brooks WM, Hart BL, Sibbitt WLJr. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 1998; 209: 79–84.
   Google Scholar
• Roman GC. Senile dementia of the Binswanger type: a vascular form of dementia in the elderly. JAMA 1987; 257: 1782–8.
   Google Scholar
• Dupont RM. Structural brain changes in mood disorder: clinical correlates and significance. Sem Clin Neuropsychia-try 1996; 1: 20–31.
   PubMedGoogle Scholar
• Brooks WM, Wesley MH, Koditawakku P, Garry PH, Rosenberg GA. 'H-MRS differentiates white matter hyper-intensities in subcortical arteriosclerotic encephalopathy from those in normal elderly. Stroke 1997; 28: 1940–3.
   Google Scholar
• Morioka C, Kondo H, Akashi K, Matsumura K, Ochi N, Makinaga G, et al. The continuous and simultaneous blood flow velocity measurement of four cerebral vessels and peripheral vessel during cigarette smoking. Psychopharmaco-logy 1997; 131: 220–9.
   Google Scholar
• Nagata K, Shinohara T, Kanno I, Hatazawa J, Domino ER Effects of tobacco and cigarette smoking on cerebral blood flow in normal adults. In: Domino EF, ed. Brain imaging of nicotine and tobacco smoking. MC: NPP Books; 1995: 95–108.
   Google Scholar
• Ghatan PH, Ingvar M, Eriksson L, Stone-Elander S, Serrander M, Ekberg K, et al. Cerebral effects of nicotine during cognition in smokers and non-smokers. Psycho-pharmacology 1998; 126: 179–89.
   Google Scholar
• Stein EA, Pankiewicz J, Harsch HH, Cho H-K, Fuller SA, Hoffmann RG, et al. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 1998; 155: 1009–15.
   Google Scholar
• Bloom AS, Hoffmann RG, Fuller SA, Pankiewicz J, Harsch HH, Stein EA. Determination of drug-induced changes in functional MRI using a pharmokinetic model. Hum Brain Mapping 1999; 8: 235–44.
   Google Scholar
• Schubert DSP. Arousal seeking as a central factor in tobacco smoking among college students. Int J Soc Psychiatry 1965; 11: 221–5.
   PubMed Web of Science ®Google Scholar
• Kozlowski LT. Effects of caffeine consumption on nicotine consumption. Psychopharmacology 1976; 47: 165–8.
   Google Scholar
• Smits P, Temme L, Mien T. The cardiovascular interaction between caffeine and nicotine in humans. Clin Pharmacol Ther 1993; 54: 194–204.
   Google Scholar
• Hyder F, Kennan RP, Kida I, Mason GF, Behar KL, Rothman D. Dependence of oxygen delivery on blood flow in rat brain: a 7 tesla nuclear magnetic resonance study. J Cereb Blood Flow Metab 2000; 20: 485–98.
   Google Scholar
• Dager SR, Strauss WL, Marro KI, Richards TL, Metzger GD, Artru AA. Proton magnetic resonance spectroscopic investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry 1995; 152: 666–72.
   Google Scholar
• Posse S, Wiese S, Gembris D, Mathiak K, Kessler C, Grosse-Ruyken ML, et al. Enhancement of BOLD-contrast sensitiv-ity by single-shot multi-echo functional MR imaging. Magn Reson Med 1999; 42: 87–97.
   Google Scholar
• Levin JM, Ross MH, Mendelson JH, Mello NK, Cohen BM, Renshaw PF. Sex differences in blood-oxygenation-level-dependent functional MRI with primary visual stimulation. Am J Psychiatry 1998; 155: 434–6.
   Google Scholar
• Ross MH, Yurgelun-Todd DA, Renshaw PF, Maas LC, Mendelson JH, Mello NK, et al. Age-related reduction in functional MRI response to phonic stimulation. Neurology 1997; 48: 173–6.
   PubMedGoogle Scholar
• Posse S, Olthoff U, Jäncke L, Weckesser M, Mäller-Gärtner HW, Dager SR. Regional dynamic signal changes during initiation of controlled hyperventilation assessed by BOLD-dependent fMRI. Am J Neuroradiol 1997; 18: 1763–70.
   Google Scholar
• Kaufman MJ, Levin JM, Maas LC, Rose SL, Lukas SE, Mendelson JH, et al. Cocaine decreases relative cerebral blood volume in humans: a dynamic susceptibility contrast magnetic resonance imaging study. Psychopharmacology 1998; 138: 76–81.
   Google Scholar
• Weckesser M, Posse S, Olthoff U, Kemna L, Dager SR, MuIler-Gärtner H-W. Functional imaging of the visual cortex with BOLD-contrast MRI: hyperventilation decreases signal response. Magn Reson Med 1999; 41: 213–6.
   Google Scholar
• Posse S, Elghahwagi B, Kemna U. Dependence of the fMRI time course of the hemodynamic response function in visual cortex on global cerebral blood flow. Proc Intl Soc Magn Reson Med 2000: 984.
   Google Scholar